Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Change in Receivables (2016 - 2025)

Sanara MedTech (SMTI) has disclosed Change in Receivables for 15 consecutive years, with $270045.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Receivables fell 89.9% year-over-year to $270045.0, compared with a TTM value of $1.9 million through Sep 2025, down 0.85%, and an annual FY2024 reading of $4.5 million, up 5101.73% over the prior year.
  • Change in Receivables was $270045.0 for Q3 2025 at Sanara MedTech, up from $243198.0 in the prior quarter.
  • Across five years, Change in Receivables topped out at $2.7 million in Q3 2024 and bottomed at -$884492.0 in Q4 2023.
  • Average Change in Receivables over 5 years is $277765.7, with a median of $88410.0 recorded in 2024.
  • The sharpest move saw Change in Receivables plummeted 3079.99% in 2023, then surged 531.83% in 2024.
  • Year by year, Change in Receivables stood at $523577.0 in 2021, then crashed by 94.33% to $29681.0 in 2022, then tumbled by 3079.99% to -$884492.0 in 2023, then surged by 295.79% to $1.7 million in 2024, then crashed by 84.41% to $270045.0 in 2025.
  • Business Quant data shows Change in Receivables for SMTI at $270045.0 in Q3 2025, $243198.0 in Q2 2025, and -$368284.0 in Q1 2025.